BARCLAYS PLC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$886
+21.7%
39,593
+16.9%
0.00%
Q2 2023$728
-12.4%
33,880
-2.2%
0.00%
Q1 2023$831
+18.5%
34,649
+14.6%
0.00%
Q4 2022$701
-99.8%
30,222
+14.8%
0.00%
Q3 2022$423,000
-42.2%
26,336
-36.3%
0.00%
Q2 2022$732,000
-26.7%
41,343
-15.7%
0.00%
-100.0%
Q1 2022$998,000
-63.2%
49,026
-66.2%
0.00%0.0%
Q4 2021$2,712,000
+63.2%
145,182
+72.5%
0.00%0.0%
Q3 2021$1,662,000
+39.5%
84,160
+66.9%
0.00%0.0%
Q2 2021$1,191,000
-31.7%
50,413
-31.5%
0.00%0.0%
Q1 2021$1,745,000
+675.6%
73,642
+554.7%
0.00%
Q4 2020$225,000
-31.4%
11,248
-28.8%
0.00%
Q3 2020$328,000
-0.9%
15,795
-16.6%
0.00%
Q2 2020$331,000
+86.0%
18,932
+74.1%
0.00%
Q1 2020$178,000
-73.1%
10,877
-66.2%
0.00%
Q4 2019$662,000
+136.4%
32,161
+31.8%
0.00%
Q3 2019$280,000
-4.4%
24,408
+9.5%
0.00%
Q2 2019$293,000
-62.7%
22,300
-57.0%
0.00%
-100.0%
Q1 2019$786,000
-2.1%
51,857
+11.0%
0.00%0.0%
Q4 2018$803,000
-63.5%
46,707
-68.7%
0.00%0.0%
Q3 2018$2,202,000
+1368.0%
149,419
+2268.0%
0.00%
Q2 2018$150,000
-45.7%
6,310
-41.3%
0.00%
Q1 2018$276,000
+196.8%
10,757
+113.3%
0.00%
Q4 2017$93,000
+1450.0%
5,044
+858.9%
0.00%
Q3 2017$6,000
+100.0%
526
+123.8%
0.00%
Q2 2017$3,000
-95.2%
235
-96.1%
0.00%
Q1 2017$62,000
-93.5%
6,091
-90.1%
0.00%
-100.0%
Q4 2016$959,000
-11.6%
61,607
+9.4%
0.00%0.0%
Q3 2016$1,085,000
+27025.0%
56,308
+17832.5%
0.00%
Q2 2016$4,000
+100.0%
314
+175.4%
0.00%
Q1 2016$2,000
-77.8%
114
-64.8%
0.00%
Q4 2015$9,000
+800.0%
324
+825.7%
0.00%
Q3 2015$1,000
-50.0%
35
-72.7%
0.00%
Q2 2015$2,0001280.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders